Ethyl (1S,2S,3S)-3-(2,4-dimethylphenyl)-2-ethyl-3-(4-fluorophenyl)sulfonylcyclopentane-1-carboxylate
C24H29FO4S — CID 134510791
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl (1S,2S,3S)-3-(2,4-dimethylphenyl)-2-ethyl-3-(4-fluorophenyl)sulfonylcyclopentane-1-carboxylate
Ethyl (1S,2S,3S)-3-(2,4-dimethylphenyl)-2-ethyl-3-(4-fluorophenyl)sulfonylcyclopentane-1-carboxylate (PubChem CID 134510791) has the molecular formula C24H29FO4S and a molecular weight of 432.56 g/mol. Its IUPAC name is ethyl (1S,2S,3S)-3-(2,4-dimethylphenyl)-2-ethyl-3-(4-fluorophenyl)sulfonylcyclopentane-1-carboxylate.
Molecular Properties
| Compound Name | Ethyl (1S,2S,3S)-3-(2,4-dimethylphenyl)-2-ethyl-3-(4-fluorophenyl)sulfonylcyclopentane-1-carboxylate |
|---|---|
| PubChem CID | 134510791 |
| Molecular Formula | C24H29FO4S |
| Molecular Weight | 432.56 g/mol |
| Exact Mass | 432.18 |
| IUPAC Name | ethyl (1S,2S,3S)-3-(2,4-dimethylphenyl)-2-ethyl-3-(4-fluorophenyl)sulfonylcyclopentane-1-carboxylate |
| SMILES | CCOC(=O)[C@H]1CC[C@](c2ccc(C)cc2C)(S(=O)(=O)c2ccc(F)cc2)[C@H]1CC |
| InChI | InChI=1S/C24H29FO4S/c1-5-21-20(23(26)29-6-2)13-14-24(21,22-12-7-16(3)15-17(22)4)30(27,28)19-10-8-18(25)9-11-19/h7-12,15,20-21H,5-6,13-14H2,1-4H3/t20-,21-,24-/m0/s1 |
| InChIKey | QNZQJNMUWVPPHR-HFMPRLQTSA-N |
| XLogP | 5.11 |
| TPSA | 60.44 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 432.56 |
| LogP ≤ 5 | 5.11 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134510791 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.